Publicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (9)

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  2. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

    Therapeutic Advances in Medical Oncology, Vol. 13

  3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  4. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

2018

  1. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database

    European Journal of Cancer, Vol. 103, pp. 205-213

2017

  1. Clinical calculator for Early mortality in Metastatic colorectal cancer: An analysis of Patients from 28 clinical trials in the aide et recherche en cancérologie digestive database

    Journal of Clinical Oncology, Vol. 35, Núm. 17, pp. 1929-1937

2016

  1. Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database

    Journal of Clinical Oncology, Vol. 34, Núm. 2, pp. 144-150

  2. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

    The Lancet Oncology, Vol. 17, Núm. 12, pp. 1709-1719

2015

  1. Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the analysis and research in cancers of the digestive system database

    Journal of Clinical Oncology, Vol. 33, Núm. 1, pp. 22-28